| Name | BLU0588 |
|---|---|
| Synonyms |
BLU-0588
N-((1R,2R)-2-(Pyrrolidin-1-yl)-2,3-dihydro-1H-inden-1-yl)-6-(1H-pyrrolo[2,3-b]pyridin-4-yl)nicotinamide BLU0588, 10 mM in DMSO 3-Pyridinecboxamide, N-[(1R,2R)-2,3-dihydro-2-(1-pyrrolidinyl)-1H-inden-1-yl]-6-(1H-pyrrolo[2,3-b]pyridin-4-yl) |
| Description | BLU0588 is an orally active, potent and selective PRKACA (protein kinase cAMP-activated catalytic subunit alpha) kinase inhibitor, with an IC50 of 1 nM and dissociation constant (Kd) of 4 nM. BLU0588 can be used for fibrolamellar carcinoma (FLC) research[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1 nM (PRKACA)[1] |
| References |
| Molecular Formula | C26H25N5O |
|---|---|
| Molecular Weight | 423.51 |